Related Experiment Video
Updated: Jul 15, 2026

Anatomical Reconstructions of the Human Cardiac Venous System using Contrast-computed Tomography of Perfusion-fixed Specimens
Published on: April 18, 2013
Prevention and treatment of contrast-induced nephropathy
Mohammed Al-Ghonaim1, Neesh Pannu
1Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Insights
Contrast-induced nephropathy (CIN) is a serious kidney complication after contrast procedures. Hemofiltration and N-acetylcysteine (NAC) show promise in preventing severe outcomes like dialysis and death in certain patients.
Area of Science:
- Nephrology
- Radiology
- Cardiology
Background:
- Contrast-induced nephropathy (CIN) is a significant cause of acute kidney injury in hospitalized patients, accounting for 10-12% of cases.
- CIN can lead to prolonged hospitalization, increased need for dialysis, and higher mortality rates.
- Risk factors include pre-existing kidney dysfunction, advanced age, diabetes, heart failure, and large contrast volumes.
Purpose of the Study:
- To review the epidemiology and risk factors associated with CIN.
- To evaluate the evidence for various prophylaxis strategies aimed at preventing CIN.
- To provide recommendations for CIN prevention and management.
Main Methods:
- Literature review of clinical trials and studies on CIN prophylaxis.
- Analysis of risk factors and their contribution to CIN development.
- Synthesis of evidence regarding the efficacy of different preventive measures.
Main Results:
- Few prophylaxis strategies have demonstrated significant benefits in reducing CIN-related complications.
- Hemofiltration and N-acetylcysteine (NAC) have shown efficacy in specific patient subgroups undergoing angiographic procedures.
- Identification of key risk factors aids in patient stratification and targeted prevention.
Conclusions:
- CIN remains a critical concern with potentially severe consequences.
- Targeted prophylaxis, particularly hemofiltration and NAC in high-risk patients, can mitigate adverse outcomes.
- Further research and adherence to evidence-based guidelines are essential for optimal CIN prevention and management.
Abstract:
Contrast-induced nephropathy (CIN) is a well-known complication of therapeutic and diagnostic procedures requiring contrast administration and accounts for 10 to 12% of acute renal failure in hospitalized patients. Although the incidence of this complication is relatively low, its consequences can be catastrophic. The development of CIN is associated with increased hospital length of stay, an increased requirement for acute dialysis, and an increased risk of death. Preexisting renal dysfunction, age, diabetes, congestive heart failure, and volume of administered contrast are all associated with a risk of developing CIN. Despite a large number of clinical trials that have evaluated prophylaxis strategies for CIN, only the use of hemofiltration and N-acetylcysteine (NAC) in specific subgroups of patients have been shown to reduce dialysis requirement and mortality in patients undergoing angiographic procedures. In this review we will discuss the epidemiology and the risk factors for CIN and the evidence for commonly employed prophylaxis strategies, and we will provide general recommendations with respect to CIN prevention and management.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies for Cardiovascular System V: CT
